Catabasis Pharmaceuticals Inc

+0.07 (+4.40%)
Earnings Announcements

Catabasis Pharmaceuticals Reports Q3 2020 Results

Published: 11/12/2020 21:49 GMT
Catabasis Pharmaceuticals Inc (CATB) - Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $0.56.
Q3 Earnings per Share Estimate $-0.51 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents Totaled $52.9 Million As of September 30, 2020.
Expects That It Has Sufficient Cash to Fund Operations for at Least Next 12 Months.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.